fluorodeoxyglucose f18 has been researched along with Cancer of Maxillary Sinus in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Balzer, B; Ho, AS; Manzoor, D; Shafqat, I; Wu, AW | 1 |
Doi, H; Fujiwara, M; Ishikura, R; Kamikonya, N; Kitajima, K; Noguchi, K; Tanooka, M; Terada, T; Yamakado, K | 1 |
Doi, H; Fukushima, K; Hirota, S; Ishikura, R; Kawanaka, Y; Kitajima, K; Mouri, M; Noguchi, K; Terada, T; Yamamoto, S | 1 |
Genden, EM; Kostakoglu, L; Lawson, WL; Lin, FY; Som, P | 1 |
Kim, BS; Kim, IJ; Kim, SJ; Kim, YK; Nam, HY; Park, K; Rho, HJ | 1 |
Gamble, BK; Ho, L; Meka, M; Seto, J; Shim, JJ | 1 |
Fischer, DR; Haerle, SK; Holzmann, D; Huber, GF; Murer, K; Soyka, MB; Strobel, K | 1 |
Hayashi, T; Higashiyama, S; Kawabe, J; Kawamura, E; Kotani, J; Kurooka, H; Oe, A; Sakamoto, H; Shiomi, S; Torii, K; Wanibuchi, H | 1 |
Nakai, Y; Ochi, H; Ohashi, Y; Okamura, T; Sakamoto, H | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Cancer of Maxillary Sinus
Article | Year |
---|---|
Management of FDG avid Benign Sinonasal Schneiderian Papilloma: A Case Report and Review of the Literature.
Topics: Adenoma, Oxyphilic; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Nasal Mucosa; Neoplasms; Papilloma, Inverted; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals | 2021 |
8 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Maxillary Sinus
Article | Year |
---|---|
Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2018 |
SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve | 2016 |
High uptake in schneiderian papillomas of the maxillary sinus on positron-emission tomography using fluorodeoxyglucose.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Nasal Mucosa; Papilloma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Detection and prediction of local recurrence of maxillary sinus cancer using F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2010 |
Left maxillary sinus malignant fibrous histiocytoma on FDG PET-CT.
Topics: Aged; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Male; Maxillary Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma.
Topics: Aged; Aged, 80 and over; Ethmoid Sinus; Female; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Melanoma; Middle Aged; Multimodal Imaging; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Two cases of maxillary cancer with a similar clinical course and imaging findings but markedly different levels of FDG uptake.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2005 |
Positron emission tomographic imaging of head and neck lesions.
Topics: Absorption; Adenoma; Aspergillosis; Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Head and Neck Neoplasms; Histiocytoma, Benign Fibrous; Humans; Magnetic Resonance Imaging; Maxillary Sinus; Maxillary Sinus Neoplasms; Maxillary Sinusitis; Nasopharyngeal Neoplasms; Papilloma; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 1997 |